Musk Announces Neuralink Success: First Human Patient Controls Mouse Using Mind
(Reuters) – The first human patient implanted with Neuralink’s brain chip appears to have fully recovered and is able to control a computer mouse with his thoughts, the startup’s founder Elon Musk said late on Monday.
“Progress is good and the patient appears to have fully recovered with no adverse effects that we are aware of. The patient is able to move the mouse on the screen just by thinking,” Musk said at the Spaces event on social media. platform X
Musk said Neuralink is now trying to get as many mouse button clicks from the patient as possible.
Neuralink did not immediately respond to Reuters’ request for more information.
The company successfully implanted the chip in its first human patient last month after receiving approval to enroll in human trials in September.
The research uses a robot to surgically place a brain-computer interface implant in the area of the brain that controls the intention to move, Neuralink has said, adding that the initial goal is to enable people to control a computer pointer or keyboard with their thoughts. .
Musk has big goals for Neuralink, saying it would facilitate rapid surgery of its chip devices to treat diseases like obesity, autism, depression and schizophrenia.
Neuralink, which was valued at around $5 billion last year, has had to repeatedly audit its security protocols. Reuters reported last month that the company was fined for violating the U.S. Department of Transportation’s rules on the transportation of hazardous materials.
(This story has been edited to correct comment in paragraph 2 “no side effects”, no “neural effects”)
